Elizabeth Arden, Inc. (RDEN) Posts Q3 Loss of 84c/Share; Will Explore Strategic Alternatives

Elizabeth Arden, Inc. (NASDAQ: RDEN) reported Q3 EPS of ($0.84), $0.84 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $210.8 million versus the consensus estimate of $256.85 million.

On an adjusted basis, excluding non-recurring items, net loss per diluted share was $0.84. The non-recurring items include Elizabeth Arden repositioning and restructuring costs. A reconciliation between GAAP and adjusted results can be found in the tables and footnotes at the end of this press release.

The Company has engaged Goldman, Sachs & Co. to assist the Board of Directors in exploring potential strategic alternatives to enhance shareholder value and to accelerate the growth and maximize the value of its brand portfolio. There can be no assurance that the Company will pursue any strategic alternatives, whether its review will result in any transaction being entered into or consummated or what the form or terms and conditions of any such strategic alternative may be. The Company does not intend to make any additional disclosure unless and until such disclosure is required.

For earnings history and earnings-related data on Elizabeth Arden, Inc. (RDEN) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• UBS Reiterates Buy Rating on Sysco (SYY) Following Trip to Company Headquarters
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation